Active

Bioenz Technologies Ltd

#662446 Private limited by shares

Bioenz Technologies Ltd is a private company limited by shares registered in Ireland on 11 December 2019 (company number 662446), based in Co. Waterford. Current status on the CRO register: Active.

Company Details

Registered Name BIOENZ TECHNOLOGIES LIMITED
Company Number 662446
Company Type Private limited by shares
Type Code 1119
Status Normal

Important Dates

Registration Date 11 December 2019
Last Annual Return 30 November 2025
Last Accounts Filed 31 May 2025

Industry Classification (NACE)

NACE Code: 74.90

Registered Address

PMBRC

WATERFORD INSTITUTE OF TECHNOLOGY

CORK ROAD WATERFORD

CO WATERFORD,WATERFORD

X91K0EK

Contact Details

Phone Number 087 372 3463
Email Address Unknown

Company Website

Company Description

BioEnz Technologies Limited is a cutting‑edge biotechnology company that turns enzyme challenges into breakthrough innovation. Leveraging a patented enzyme‑discovery platform and a unique, proprietary microbial biobank of more than 4,500 characterised microorganisms, BioEnz delivers next‑generation, custom‑designed enzymes that boost efficiency, yield and product purity across a range of industrial processes.

The firm’s core services include accelerated (up to ten‑fold) enzyme discovery, bespoke enzyme development and rapid response to specific process hurdles. Its expertise spans key sectors such as biofuels, where it enhances conversion efficiency and reduces waste; food and beverage production, improving safety, flavour stability and overall process performance; sustainable agriculture, optimising resource use and crop outcomes; and therapeutic applications, providing targeted enzyme solutions for advanced disease treatment.

Backed by a team of seasoned scientists and industry veterans—including CEO Tim Roche and Dr Lee Coffey, a recognised leader in enzyme discovery—BioEnz combines over three decades of collective experience with a 20‑year research legacy to provide agile, reliable solutions that keep partners ahead in a fast‑evolving market.